Publisher： Karger
E-ISSN： 1423-0232|76|3|184-189
ISSN： 0030-2414
Source： Oncology, Vol.76, Iss.3, 2009-02, pp. : 184-189
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Carmustine (BCNU) plus Teniposide (VM26) in Recurrent Malignant Glioma
Oncology, Vol. 86, Iss. 5-6, 2014-06 ,pp. :
Access to resources
Recommend
Challenges in clinical trial design for recurrent glioblastoma
By McNeill Katharine A Fine Howard A
Clinical Investigation, Vol. 3, Iss. 9, 2013-09 ,pp. :
Second-Line Chemotherapy in Recurrent Glioblastoma - Still Controversial
Oncology Research and Treatment, Vol. 38, Iss. 7-8, 2015-07 ,pp. :
Second-Line Chemotherapy in Recurrent Glioblastoma: A 2-Cohort Study
Oncology Research and Treatment, Vol. 38, Iss. 7-8, 2015-06 ,pp. :
Bevacizumab and irinotecan for glioblastoma
PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 1, 2015-02 ,pp. :